Skip to main content
. 2019 Oct 11;11(10):522. doi: 10.3390/pharmaceutics11100522

Figure 13.

Figure 13

GALNS activity (left graph) and reduction of the glycosaminoglycan (GAG) lysosomal deposits of pathological fibroblasts before and after incubation in a suspension of elosulfase alfa-NLC.